Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) EBT: 2019-2024

Historic EBT for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to -$37.7 million.

  • MDxHealth's EBT rose 26.15% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.7 million, marking a year-over-year increase of 23.90%. This contributed to the annual value of -$37.7 million for FY2024, which is 12.56% up from last year.
  • Per MDxHealth's latest filing, its EBT stood at -$37.7 million for FY2024, which was up 12.56% from -$43.1 million recorded in FY2023.
  • MDxHealth's 5-year EBT high stood at -$28.7 million for FY2020, and its period low was -$44.0 million during FY2022.
  • For the 3-year period, MDxHealth's EBT averaged around -$41.6 million, with its median value being -$43.1 million (2023).
  • As far as peak fluctuations go, MDxHealth's EBT skyrocketed by 34.37% in 2020, and later tumbled by 51.87% in 2022.
  • MRY analysis of 5 years shows MDxHealth's EBT stood at -$28.7 million in 2020, then fell by 1.19% to -$29.0 million in 2021, then plummeted by 51.87% to -$44.0 million in 2022, then grew by 2.15% to -$43.1 million in 2023, then grew by 12.56% to -$37.7 million in 2024.
  • Its EBT stands at -$37.7 million for FY2024, versus -$43.1 million for FY2023 and -$44.0 million for FY2022.